Synthesis and Pharmacological Evaluation of Enantiopure N-Substituted Ortho-c Oxide-Bridged 5-Phenylmorphans

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2022 Dec 23

PMID 36557961

Authors

Fuying Li

Theresa A Kopajtic

Jonathan L Katz

Dan Luo

Thomas E Prisinzano

Gregory H Imler

Jeffrey R Deschamps

Arthur E Jacobson

Kenner C Rice

Affiliations

Soon will be listed here.

Abstract

The design of enantiopure stereoisomers of N-2-phenylcyclopropylmethyl-substituted ortho-c oxide-bridged phenylmorphans, the E and Z isomers of an N-cinnamyl moiety, and N-propyl enantiomers were based on combining the most potent oxide-bridged phenylmorphan (the ortho-c isomer) with the most potent N-substituent that we previously found with a 5-(3-hydroxy)phenylmorphan (i.e., N-2-phenylcyclopropyl methyl moieties, N-cinnamyl, and N-propyl substituents). The synthesis of the eight enantiopure N-2-phenylcyclopropylmethyl ortho-c oxide-bridged phenylmorphans and six additional enantiomers of the N-substituted ortho-c oxide-bridged phenylmorphans (N-E and Z-cinnamyl compounds, and N-propyl compounds) was accomplished. The synthesis started from common intermediates (3R,6aS,11aS)-10-methoxy-1,3,4,5,6,11a-hexahydro-2H-3,6a-methano-benzofuro[2,3-c]azocine (+)-6 and its enantiomer, (3S, 6aR, 11aR)-(-)-6, respectively. The enantiomers of ±-6 were obtained through salt formation with (S)-(+)- and (R)-(-)-p-methylmandelic acid, and the absolute configuration of the (R)-(-)-p-methylmandelate salt of (3S, 6aR, 11aR)-(-)-6 was determined by single-crystal X-ray analysis. The enantiomeric secondary amines were reacted with N-(2-phenylcyclopropyl)methyl derivatives, 2-(E)-cinnamyl bromide, and (Z)-3-phenylacrylic acid. These products led to all of the desired N-derivatives of the ortho-c oxide-bridged phenylmorphans. Their opioid receptor binding affinity was measured. The compounds with MOR affinity < 50 nM were examined for their functional activity in the forskolin-induced cAMP accumulation assay. Only the enantiomer of the N-phenethyl ortho-c oxide-bridged phenylmorphan ((-)-1), and only the (3S,6aR,11aR)-2-(((1S,2S)-2-phenylcyclopropyl)methyl)-1,3,4,5,6,11a-hexahydro-2H-3,6a-methanobenzofuro[2,3-c]azocin-10-ol isomer ((+)-17), and the N-phenylpropyl derivative ((-)-25) had opioid binding affinity < 50 nM. Both (-)-1 and (-)-25 were partial agonists in the cAMP assay, with the former showing high potency and low efficacy, and the latter with lower potency and less efficacy. Most interesting was the N-2-phenylcyclopropylmethyl (3S,6aR,11aR)-2-(1S,2S)-enantiomer ((+)-17). That compound had good MOR binding affinity (Ki = 11.9 nM) and was found to have naltrexone-like potency as a MOR antagonist (IC50 = 6.92 nM).

References

Kim J, Deschamps J, Rothman R, Dersch C, Folk J, Cheng K . Probes for narcotic receptor mediated phenomena. Part 42: synthesis and in vitro pharmacological characterization of the N-methyl and N-phenethyl analogues of the racemic ortho-c and para-c oxide-bridged phenylmorphans. Bioorg Med Chem. 2011; 19(11):3434-43. PMC: 3115714. DOI: 10.1016/j.bmc.2011.04.028. View

Riley A, Groer C, Young D, Ewald A, Kivell B, Prisinzano T . Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues. J Med Chem. 2014; 57(24):10464-75. PMC: 4281103. DOI: 10.1021/jm501521d. View

Gunther T, Dasgupta P, Mann A, Miess E, Kliewer A, Fritzwanker S . Targeting multiple opioid receptors - improved analgesics with reduced side effects?. Br J Pharmacol. 2017; 175(14):2857-2868. PMC: 6016677. DOI: 10.1111/bph.13809. View

Hedrick S, Luo D, Kaska S, Niloy K, Jackson K, Sarma R . Design, synthesis, and preliminary evaluation of a potential synthetic opioid rescue agent. J Biomed Sci. 2021; 28(1):62. PMC: 8427951. DOI: 10.1186/s12929-021-00758-y. View

Stahl E, Bohn L . Low Intrinsic Efficacy Alone Cannot Explain the Improved Side Effect Profiles of New Opioid Agonists. Biochemistry. 2021; 61(18):1923-1935. PMC: 8885792. DOI: 10.1021/acs.biochem.1c00466. View

Kodato S, Linders J, Gu X, Yamada K, Flippen-Anderson J, Deschamps J . Synthesis of rac-(1R,4aR,9aR)-2-methyl-1,3,4,9a-tetrahydro-2H-1,4a-propanobenzofuro[2,3-c]pyridin-6-ol. An unusual double rearrangement leading to the ortho- and para-f oxide-bridged phenylmorphan isomers. Org Biomol Chem. 2004; 2(3):330-6. DOI: 10.1039/b312633c. View

Burke Jr T, JACOBSON A, Rice K, Weissman B, Silverton J . Probes for narcotic receptor mediated phenomena 3. Oxide bridged 5-phenylmorphans. NIDA Res Monogr. 1984; 49:109-13. View

Machelska H, Celik M . Advances in Achieving Opioid Analgesia Without Side Effects. Front Pharmacol. 2018; 9:1388. PMC: 6282113. DOI: 10.3389/fphar.2018.01388. View

Kurimura M, Liu H, Sulima A, Hashimoto A, Przybyl A, Ohshima E . Probes for narcotic receptor mediated phenomena. 37. Synthesis and opioid binding affinity of the final pair of oxide-bridged phenylmorphans, the ortho- and para-b-isomers and their N-phenethyl analogues, and the synthesis of the N-phenethyl.... J Med Chem. 2008; 51(24):7866-81. PMC: 2605521. DOI: 10.1021/jm800913d. View

10.

Cheng K, Lee Y, Rothman R, Dersch C, Bittman R, Jacobson A . Probes for narcotic receptor mediated phenomena. 41. Unusual inverse μ-agonists and potent μ-opioid antagonists by modification of the N-substituent in enantiomeric 5-(3-hydroxyphenyl)morphans. J Med Chem. 2011; 54(4):957-69. PMC: 3047451. DOI: 10.1021/jm1011676. View

11.

Azevedo Neto J, Costanzini A, De Giorgio R, Lambert D, Ruzza C, Calo G . Biased versus Partial Agonism in the Search for Safer Opioid Analgesics. Molecules. 2020; 25(17). PMC: 7504468. DOI: 10.3390/molecules25173870. View

12.

Crowley R, Riley A, Alder A, Anderson 3rd R, Luo D, Kaska S . Synthetic Studies of Neoclerodane Diterpenes from : Design, Synthesis, and Evaluation of Analogues with Improved Potency and G-protein Activation Bias at the μ-Opioid Receptor. ACS Chem Neurosci. 2020; 11(12):1781-1790. PMC: 7359744. DOI: 10.1021/acschemneuro.0c00191. View

13.

Zezula J, Singer L, Przybyl A, Hashimoto A, Dersch C, Rothman R . Synthesis and pharmacological effects of the enantiomers of the N-phenethyl analogues of the ortho and para e- and f-oxide-bridged phenylmorphans. Org Biomol Chem. 2008; 6(16):2868-83. PMC: 2507883. DOI: 10.1039/b803433h. View

14.

Cheng K, Kim I, Lee M, Adah S, Raymond T, Bilsky E . Opioid ligands with mixed properties from substituted enantiomeric N-phenethyl-5-phenylmorphans. Synthesis of a micro-agonist delta-antagonist and delta-inverse agonists. Org Biomol Chem. 2007; 5(8):1177-1190. DOI: 10.1039/b618875c. View

15.

Burke Jr T, JACOBSON A, Rice K, Weissman B, Huang H, Silverton J . Probes for narcotic receptor mediated phenomena. 9. Synthesis of (+/-)-(3 alpha,6a alpha,11a beta)-1,3,4,5,6,11a-hexahydro-2-methyl-2H-3,6a- methanobenzofuro[2,3-c]azocin-10-ol, an oxide-bridged 5-(m-hydroxyphenyl)morphan. J Med Chem. 1986; 29(5):748-51. DOI: 10.1021/jm00155a026. View

16.

Hashimoto A, Przybyl A, Linders J, Kodato S, Tian X, Deschamps J . Probes for narcotic receptor-mediated phenomena. 33. Construction of a strained trans-5,6-ring system by displacement of a nitro-activated aromatic fluorine. synthesis of the penultimate oxide-bridged phenylmorphans. J Org Chem. 2004; 69(16):5322-7. DOI: 10.1021/jo040159k. View